Cardiovascular Health Promotion and Disease Prevention in China: Calling for New-Era Strategies

Xi Li; Jun Lv; An Pan; Yuan Lu; Jun Cai; Jing Li; Jiapeng Lu; Xiangfeng Lu; Zengwu Wang; Haibo Zhang; Yaohua Tian; Chunying Lin; Yi Wu; Zhiyi Chen; Shengshou Hu

doi:10.1016/j.jacasi.2026.03.033

Cardiovascular Health Promotion and Disease Prevention in China: Calling for New-Era Strategies

JACC Asia. 2026 May 27:S2772-3747(26)00244-9. doi: 10.1016/j.jacasi.2026.03.033. Online ahead of print.

Authors

Xi Li¹, Jun Lv², An Pan³, Yuan Lu⁴, Jun Cai⁵, Jing Li⁵, Jiapeng Lu⁵, Xiangfeng Lu⁵, Zengwu Wang⁵, Haibo Zhang⁵, Yaohua Tian³, Chunying Lin⁵, Yi Wu⁵, Zhiyi Chen², Shengshou Hu⁶

Affiliations

¹ National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, Shenzhen, China; Central China Sub-center of the National Center for Cardiovascular Diseases, Zhengzhou, China. Electronic address: xi.li@nccd.org.cn.
² State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education; Department of Epidemiology and Biostatistics, School of Public Health, Peking University; Peking University Center for Public Health and Epidemic Preparedness and Response, Beijing, China.
³ School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
⁴ Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA; Center for Outcomes Research and Evaluation, Yale/Yale New Haven Health, New Haven, Connecticut, USA.
⁵ National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
⁶ National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, Shenzhen, China. Electronic address: huss@fuwaihospital.org.

PMID: 42246896
DOI: 10.1016/j.jacasi.2026.03.033

Abstract

China has prioritized the prevention of cardiovascular disease. Over the past decade, significant investments have been made in public health services, along with the implementation of various health promotion policy agendas. As a result, environmental cardiovascular hazards have been substantially reduced, and care coverage within the primary health care system has improved. Nevertheless, adherence to various healthy lifestyles within the population has exhibited different secular trends, meanwhile the underutilization of secondary prevention medications among vulnerable populations is concerning. The Healthy China Initiative 2030 outlines a roadmap to prevent, pre-empt, and mitigate cardiovascular disease. China, along with other developing countries facing similar challenges, should consider fostering supportive social environments for healthy behaviors, targeting vulnerable groups for lifestyle adherence and access to care, expanding the scope of services provided by primary care providers, leveraging new technologies to develop scalable tools, and integrating surveillance systems for health promotion and care.

Keywords: cardiovascular disease; cardiovascular disease prevention; health promotion.

Publication types

Review